Epidemiology Branch, Division of Epidemiology, Statistics, and Prevention Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, Rockville, Maryland 20852, USA.
J Clin Endocrinol Metab. 2010 Sep;95(9):E80-5. doi: 10.1210/jc.2010-0109. Epub 2010 Jun 9.
Exogenous estrogens have been shown to affect the lipid profile, leading to the hypothesis that endogenous estrogens may have similar effects.
The objective of the study was to evaluate the association between endogenous estrogen and serum lipoproteins across the menstrual cycle.
This was a prospective cohort study.
The study was conducted at the University at Buffalo, 2005-2007.
Participants included 259 healthy, regularly menstruating women aged 18-44 yr.
Serum levels of total, high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol, and triglycerides measured up to eight times per cycle for up to two cycles were measured.
Total and LDL cholesterol were lower during the luteal phase as compared with the follicular phase (P < 0.001), and HDL levels were highest around ovulation (P < 0.001). More women were classified above the desirable range (LDL > or =130 mg/dl or total cholesterol > or =200 mg/dl) when measured during the follicular phase. Estradiol was positively associated with HDL in acute effects models [beta = 0.019, 95% confidence interval (CI) 0.015, 0.022] and inversely associated with total (beta = -0.017, 95% CI -0.020, -0.014) and LDL cholesterol (beta = -0.023, 95% CI -0.027, -0.018) and triglycerides (beta = -0.041, 95% CI -0.054, -0.029) in persistent effects models.
Endogenous estrogen, like exogenous estrogen, appears to have beneficial effects on the lipid profile. Because lipoprotein cholesterol levels vary across the menstrual cycle, cyclic variations in lipoprotein levels may need to be considered in the design and interpretation of studies in reproductive-age women and in the clinical management of women's cholesterol.
外源性雌激素已被证明会影响血脂谱,从而产生内源性雌激素可能具有类似影响的假说。
本研究旨在评估整个月经周期内内源性雌激素与血清脂蛋白之间的关系。
这是一项前瞻性队列研究。
该研究于 2005-2007 年在布法罗大学进行。
参与者包括 259 名年龄在 18-44 岁之间、健康且有规律月经的女性。
在每个周期中最多测量 8 次,共测量 2 个周期,以测量总胆固醇、高密度脂蛋白(HDL)和低密度脂蛋白(LDL)胆固醇以及甘油三酯的血清水平。
总胆固醇和 LDL 胆固醇在黄体期比卵泡期低(P <0.001),HDL 水平在排卵时最高(P <0.001)。当在卵泡期测量时,更多的女性被归类为理想范围以上(LDL >或= 130mg/dl 或总胆固醇 >或= 200mg/dl)。在急性效应模型中,雌二醇与 HDL 呈正相关[β=0.019,95%置信区间(CI)0.015,0.022],与总胆固醇(β=-0.017,95%CI -0.020,-0.014)和 LDL 胆固醇(β=-0.023,95%CI -0.027,-0.018)以及甘油三酯(β=-0.041,95%CI -0.054,-0.029)呈负相关。在持续效应模型中。
内源性雌激素与外源性雌激素一样,似乎对血脂谱有有益的影响。由于脂蛋白胆固醇水平在月经周期中变化,因此在设计和解释生殖年龄女性的研究以及女性胆固醇的临床管理中,可能需要考虑脂蛋白水平的周期性变化。